Insiders who reported open-market trades in the last 12 months at the companies Gary Ingenito files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Brian Elsbernd - $908K in CPRX purchases and sales in the last 12 months
Molly Harper - $622K in CPRX purchases and sales in the last 12 months
Carmen Jeffrey del - $256K in CPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Gary Ingenito is a corporate insider, tracked as Chief Med. Reg. Officer of CATALYST PHARMACEUTICALS, INC. (CPRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gary Ingenito last file a Form 4?
The most recent primary Form 4 on record is dated 13 May 2025, one of 6 filings going back to 2024.
Has Gary Ingenito been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($6.85M) across all tracked filings.
Gary Ingenito is Chief Med. Reg. Officer of CATALYST PHARMACEUTICALS, INC. (CPRX). 6 SEC Form 4 filings on record going back to 2024, most recently on 13 May 2025. Most recent open-market trade: sold $1.04M of CPRX on 13 May 2025. Lifetime open-market sales: $6.85M.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Gary Ingenito.
InsiderAlpha's records for Gary Ingenito go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
